BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22947336)

  • 1. Expression profile of telomere-associated genes in multiple myeloma.
    Díaz de la Guardia R; Catalina P; Panero J; Elosua C; Pulgarin A; López MB; Ayllón V; Ligero G; Slavutsky I; Leone PE
    J Cell Mol Med; 2012 Dec; 16(12):3009-21. PubMed ID: 22947336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.
    Panero J; Stella F; Schutz N; Fantl DB; Slavutsky I
    PLoS One; 2015; 10(9):e0137972. PubMed ID: 26366868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.
    Wang F; Yin Y; Ye X; Liu K; Zhu H; Wang L; Chiourea M; Okuka M; Ji G; Dan J; Zuo B; Li M; Zhang Q; Liu N; Chen L; Pan X; Gagos S; Keefe DL; Liu L
    Cell Res; 2012 Apr; 22(4):757-68. PubMed ID: 22184006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere shortening in patients with plasma cell disorders.
    Cottliar A; Pedrazzini E; Corrado C; Engelberger MI; Narbaitz M; Slavutsky I
    Eur J Haematol; 2003 Nov; 71(5):334-40. PubMed ID: 14667196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Panero J; Arbelbide J; Fantl DB; Rivello HG; Kohan D; Slavutsky I
    Mol Med; 2010; 16(11-12):471-8. PubMed ID: 20644899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
    Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
    Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
    Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N
    Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.
    Ria R; Todoerti K; Berardi S; Coluccia AM; De Luisi A; Mattioli M; Ronchetti D; Morabito F; Guarini A; Petrucci MT; Dammacco F; Ribatti D; Neri A; Vacca A
    Clin Cancer Res; 2009 Sep; 15(17):5369-78. PubMed ID: 19690192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere dynamics and homeostasis in a transmissible cancer.
    Ujvari B; Pearse AM; Taylor R; Pyecroft S; Flanagan C; Gombert S; Papenfuss AT; Madsen T; Belov K
    PLoS One; 2012; 7(8):e44085. PubMed ID: 22952882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
    Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
    Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression.
    Panero J; Stanganelli C; Arbelbide J; Fantl DB; Kohan D; García Rivello H; Rabinovich GA; Slavutsky I
    Blood Cells Mol Dis; 2014; 52(2-3):134-9. PubMed ID: 24239198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation.
    Chang H; Yeung J; Xu W; Ning Y; Patterson B
    Br J Haematol; 2006 Sep; 134(6):613-5. PubMed ID: 16889615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromosomal abnormalities and clonal evolution in multiple myeloma].
    Ishida T
    Rinsho Ketsueki; 2014 Oct; 55(10):2036-45. PubMed ID: 25297769
    [No Abstract]   [Full Text] [Related]  

  • 14. Telomerase promotes formation of a telomere protective complex in cancer cells.
    Perera ON; Sobinoff AP; Teber ET; Harman A; Maritz MF; Yang SF; Pickett HA; Cesare AJ; Arthur JW; MacKenzie KL; Bryan TM
    Sci Adv; 2019 Oct; 5(10):eaav4409. PubMed ID: 31616780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.
    Brennan SK; Wang Q; Tressler R; Harley C; Go N; Bassett E; Huff CA; Jones RJ; Matsui W
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EWSR1 overexpression is a pro-oncogenic event in multiple myeloma.
    Nishiyama D; Chinen Y; Isa R; Fujibayashi Y; Kuwahara-Ota S; Yamaguchi J; Takimoto-Shimomura T; Matsumura-Kimoto Y; Tsukamoto T; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Handa H; Kuroda J
    Int J Hematol; 2021 Mar; 113(3):381-394. PubMed ID: 33095415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of telomere length dynamics in induced pluripotent stem cells using quantitative fluorescence in situ hybridization.
    Terai M; Izumiyama-Shimomura N; Aida J; Ishikawa N; Kuroiwa M; Poon SS; Arai T; Toyoda M; Akutsu H; Umezawa A; Nakamura K; Takubo K
    Tissue Cell; 2013 Dec; 45(6):407-13. PubMed ID: 23928219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Nuclear Organization of Telomeresand Centromeres in Monoclonal Gammopathyof Undetermined Significance and Multiple Myeloma.
    Yu PLI; Wang Y; Tammur P; Tamm A; Punab M; Rangel-Pozzo A; Mai S
    Cells; 2019 Jul; 8(7):. PubMed ID: 31311193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous Nuclear Ribonucleoproteins Involved in the Functioning of Telomeres in Malignant Cells.
    Shishkin SS; Kovalev LI; Pashintseva NV; Kovaleva MA; Lisitskaya K
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.